Immunis.AI

Royal Oak, Michigan, United States

AI / ML Diagnostics Molecular Diagnostics Cancer

Developer of a non-invasive blood-based immunogenomic platform discovery platform designed to detect cancer and other diseases that individuals may be harboring and the body's immune response to those diseases The company's platform uses machine learning to perform detailed genomic analysis of patient blood samples to understand diseases by analyzing differential gene expression patterns to characterize the disease and identifies novel biomarkers and biological pathways, thereby helping clinicians and pharmaceutical developers to improve sensitive small tumor profiling that can be used for screening, diagnosis, prognosis, and surveillance.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Immunis.AI on @MedStartr Today #AutoimmuneDiseases #InfectiousDiseases #Diagnostics #AIML #MolecularDiagnostics #Cancer #MedMo #MedStartrVentures

https://www.medstartr.ai/s/Bw3QhV3rwKM

Get Involved in Immunis.AI

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2019
Website: immunis.ai/

Disease Areas

Autoimmune Disease Infectious Diseases Diagnostics

Technologies

Machine LearningGenomicsLiquid BiopsyBiomarkers

🌐Website

What do you think of Immunis.AI?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.